Terumo Website Feed

December 8, 2022
Ultimaster Drug Eluting Stent family (Terumo) first stent to receive the mention 1-month DAPT in the reimbursement conditions in France
April 12, 2023
Notice Concerning Partial Amendments to the Articles of Incorporation
August 1, 2023
Terumo Blood and Cell Technologies’ Reveos® Automated Whole Blood Processing System Cleared by FDA for U.S. Commercial Use
November 30, 2023
Terumo expands global presence with new subsidiary in South-Africa
December 6, 2022
Terumo Announces Launch of Drug-Device Combination Product Co-Developed with Kyowa Kirin
April 24, 2023
Terumo Group’s Targets for Greenhouse Gas Reduction Approved by the SBT Initiative as 1.5°C Aligned
August 2, 2023
Notice of Completion of Disposal of Treasury Shares as Restricted Stock Remuneration Plan
December 2, 2022
Notification Regarding Status of Acquisition of the Company's Own Shares
April 21, 2023
Terumo Aortic Announces First Implant of Innovative Custom-made Thoracoabdominal Hybrid Device in North America
August 2, 2023
Notice Concerning the Determination of Details of Issuance of Stock Options (Share Warrants)
December 1, 2022
Terumo Announces All Dexcom G6 CGM System Users on Insulin Therapy to be Covered by Insurance in Japan
April 26, 2023
Ultimaster Nagomi™ MDR certification and launch of large-scale post-market study investigating the new coronary stent system in complex PCI
August 9, 2023
Notice Concerning Acquisition of Own Shares and Cancellation of Treasury Stock
January 18, 2023
First Patient Treated and Enrolled in Terumo Medical Corporation’s Osprey Iliac IDE Clinical Trial
May 5, 2023
Terumo Aortic Announces FDA Approval of Dissection and Transection Indication Expansion for the RELAY®Pro Stent-graft System in the United States
August 9, 2023
Notice of Stock Change of Olympus Terumo Biomaterials
January 25, 2023
Terumo and Siemens Healthineers India collaborate to strengthen cardiac care in India
May 15, 2023
Terumo to Construct a New Manufacturing Facility at its Kofu Factory for the Medical Care Solutions Company
September 4, 2023
Notice Concerning the Status of the Acquisition of Own Shares
January 26, 2023
Terumo Group to Establish the Sustainability Committee
May 15, 2023
Terumo Appoints the Candidates for Directors
September 15, 2023
Terumo Group Associates Celebrate Terumo Patient’s Day 2023
February 9, 2023
Terumo to Revise Performance Evaluation System for Executive Officers
May 25, 2023
Terumo Blood and Cell Technologies Optimizing Cell Therapy Production Through Industry’s First Apheresis Training for Cell Therapy Manufacturers
October 2, 2023
Terumo to Cease Distributing Dexcom Continuous Glucose Monitoring Systems as Dexcom Moves to a Direct Distribution Model in Japan
February 9, 2023
Terumo Announces Change of Executive Officers
June 13, 2023
Terumo Aortic Announces Launch of the Global Thoraflex Hybrid EXTEND Study
October 3, 2023
Notice Concerning the Status of the Acquisition of Own Shares
February 9, 2023
Notice Concerning Revision of the Year-end Dividend Forecast for Fiscal Year Ending March 31, 2023 (Dividend Increase)
June 27, 2023
Terumo Announces Voting Results for the Election of Directors
October 5, 2023
Terumo Blood and Cell Technologies launches study with BioCentriq® to generate public CAR-T cell data using Terumo BCT’s CGT manufacturing platforms
February 9, 2023
Notice Concerning Revision of the Full-Year Financial Guidance for Fiscal Year Ending March 31, 2023 (FY2022)
July 4, 2023
Terumo Aortic Announces PMDA Approval for Thoraflex Hybrid in Japan
October 4, 2023
ANGIO-SEAL™ VIP & FEMOSEAL™ VASCULAR CLOSURE DEVICES SECURED CE CERTIFICATE UNDER THE NEW MEDICAL DEVICE REGULATION
February 23, 2023
Terumo Blood and Cell Technologies Presents First Quantum Flex Data for Multiple Size Bioreactors Showing Rapid T-Cell Expansion to Numbers Equivalent to a Therapeutic Dose
July 13, 2023
Notice Regarding Disposal of Treasury Shares as Restricted Stock Remuneration
October 31, 2023
Olympus and Terumo Announce Change in Form of Contract
February 22, 2023
Terumo India Partners with Siemens Healthineers to Introduce First of Its Kind Programme for Cathlab Directors in Collaboration with ISB Executive Education
July 13, 2023
Notice Concerning the Issuance of Stock Options (Share Warrants)
November 2, 2023
Notice Concerning the Status of the Acquisition of Own Shares
February 14, 2023
Terumo Blood and Cell Technologies’ IMUGARD Platelet Pooling Set Cleared by FDA
July 11, 2023
Terumo India recognized among India's Great Mid-Size Workplaces™
November 11, 2023
Terumo India Advances Liver Cancer Care in India with the Launch of Occlusafe™ & LifePearl™
March 2, 2023
Terumo to Further Drive DE&I by Establishing Focus Areas to Commit Globally
July 31, 2023
MicroVention Celebrates One-Year Anniversary of FRED™ X Flow Diverter with Over 1,000 Patients Treated Across the U.S.
November 6, 2023
908 Devices and Terumo Blood and Cell Technologies Collaborate to Add On-line Analytics to Quantum Flex Cell Expansion System
December 12, 2022
Notification of Completion of Acquisition and Cancellation of Own Shares
March 7, 2023
Terumo Prospective Registry Reinforces Safety, Efficacy and Efficiency of Radial Access in Visceral Interventions (R.A.V.I.) in Embolization Procedures
July 31, 2023
MicroVention Announces 5-Year Clinical Trial Data and Size Additions for its WEB Aneurysm Embolization System; WEB is Most Well-Studied Intrasaccular Device Available Today
November 14, 2023
Terumo India Introduces Insulin Syringe for Patients Requiring Daily Insulin Injections to Manage Diabetes
View all